Fluonco, 5-FU, is one of the latest additions to Ambica’s line of Onco products. It is used for colorectal cancer, pancreatic cancer, and sometimes in the treatment of inflammatory breast cancer. It has been used as an anti neoplastic drug for decades.

Ambica’s tamoxifen tablet, Xifen, is an estrogen receptor agonist used for the treatment of both early and advanced ER+ (estrogen receptor positive) breast cancer in pre- and post-menopausal women. It is an oral chemo drug which may be taken for up to 5 years. It is available in 10 mg or 20 mg dose preparation.

Txol, anastrozole 1 mg tablet,  is an oral aromatase inhibitor which inhibits estrogen synthesis. It is used in the treatment of hormone-receptive breast cancer after surgery to reduce the risk for recurrence. It can be used as monotherapy or add on to other chemotherapeutic drugs targeting breast cancer.

Letoripe is an oral non-steroidal aromatase inhibitor approved for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. It comes in 2.5 mg/ tablet.